Key result
Resistant hypertension is a common clinical problem with an unfavorable prognosis, and its prevalence is expected to increase due to rising rates of obesity, diabetes, older age, and chronic kidney disease.
Resistant hypertension is a growing clinical challenge driven by increasing rates of obesity, diabetes, and chronic kidney disease, requiring careful exclusion of pseudoresistance.
Answers are grounded in this paper and cite their sources.
May indicate higher complication risk in resistant hypertension; leaves open accurate prevalence and prognosis from proper population studies.
Resistant hypertension is an entity that has gained a lot of attention in recent years. The prevalence and prognosis of resistant hypertension have not yet been examined by proper population studies, but data from several sources suggest that this entity is not uncommon and is associated with an elevated risk of hypertensive complications. Moreover, several factors and conditions that can interfere with blood pressure control such as excess sodium intake, obesity, diabetes, older age, kidney disease, and certain identifiable causes of hypertension were shown to be common among patients with resistance to antihypertensive treatment. Importantly, the prevalence of several of these conditions has been increasing continuously during the past years, suggesting a future increase in the frequency of resistant hypertension. This article will discuss current knowledge and associated future implications relevant to the epidemiology of resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Pantelis Sarafidis (2011) conducted a review in Resistant Hypertension. Resistant hypertension is a common clinical problem with an unfavorable prognosis, and its prevalence is expected to increase due to rising rates of obesity, diabetes, older age, and chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: